1. A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting. (June 2015) Authors: Dranitsaris, G; Beegle, N; Kalberer, T; Blau, S; Cox, D; Faria, C Journal: Journal of oncology pharmacy practice Issue: Volume 21:Number 3(2015:Sep.) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗